Equities

Novo Integrated Sciences Inc

NVOS:NAQ

Novo Integrated Sciences Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.309
  • Today's Change-0.019 / -5.79%
  • Shares traded218.84k
  • 1 Year change-88.45%
  • Beta-0.6912
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Aug 31 2023202320222021
ASSETS
Cash And Short Term Investments0.422.188.29
Total Receivables, Net2.522.102.28
Total Inventory1.110.880.34
Prepaid expenses0.350.570.22
Other current assets, total------
Total current assets4.395.7311
Property, plant & equipment, net7.378.478.61
Goodwill, net7.587.839.08
Intangibles, net161932
Long term investments------
Note receivable - long term--00.69
Other long term assets----0
Total assets364162
LIABILITIES
Accounts payable3.511.801.45
Accrued expenses2.002.121.99
Notes payable/short-term debt1.099.580.48
Current portion long-term debt/capital leases1.210.014.51
Other current liabilities, total0.100.570.04
Total current liabilities7.90148.46
Total long term debt0.071.126.13
Total debt2.361111
Deferred income tax1.401.451.50
Minority interest(0.32)(0.26)(0.06)
Other liabilities, total1.692.192.06
Total liabilities111918
SHAREHOLDERS EQUITY
Common stock1.239.519.26
Additional paid-in capital916655
Retained earnings (accumulated deficit)(67)(54)(21)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.36)0.560.99
Total equity252244
Total liabilities & shareholders' equity364162
Total common shares outstanding163.122.66
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.